论文部分内容阅读
倍必可简明处方资料Symbicort_V/⑶2010-11-22丨成分1本品为复方制剂.其组份为布地奈德和茁马敌福奠特罗mm(1)80?[克/4.5抛克/吸,60吸/支(2>160微克/4.5微克>吸,60吸;支I适应症]1.哮端本品适用于霈耍联合应用吸入皮质激索和长效(J 2~受体激动剂的啤喘病人的常规治疗胃注意:本品(80微克/4 5撖克/吸)不适用子严重哮喘患者2.慢性陌塞性肺病(COPD)针对患者C0PD(FEV1矣预计正常值的50%)和伴有病情反复发作恶化的患者进行对症治疗【用法用置】1哮喘对子本品.有两种使用方法:A.维持治疗:本品作为常规维持治疗.另配快速起效的支气管扩张剂作为缧
Times will be concise prescription information Symbicort_V / ⑶ 2010-11-22 丨 Ingredients 1 This product is a compound preparation. Its components are budesonide and marcfort fumitro mm (1) 80? [G / 4.5 throw g / Suction, 60 Suction / Branch (2> 160 μg / 4.5 μg> Suction, 60 Suction; Indications for Branch I] 1. Asthma This product is suitable for use in combination with inhaled cortical irritants and long-acting Agonist of the general treatment of patients with psoriasis Note: This product (80 micrograms / 45 grams / absorption) does not apply sub-severe asthma patients 2. Chronic Parkinson's Disease (COPD) for patients with COPD (FEV1 carry the expected normal Of 50%) and patients with recurrent exacerbations of symptomatic treatment [Usage] 1 asthma on the sub-product.There are two ways to use: A. Maintenance treatment: This product as a routine maintenance treatment. Effective bronchodilator as 缧